dm+d
82165003
Lactation Safety Information
Hydralazine
Unlicensed in UK for phaechromocytoma-related hypertension
No published evidence of safety
Withhold breastfeeding for 2 hours after last maternal dose
Monitor infant for hypotension
31 July 2020